|
| |
Ankylosing SpondylitisDownload PDF containing detailed information.
Recent Publications on Ankylosing Spondylitis: |  |
An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population.
Objective: To investigate the prevalence of low back pain (LBP) and axial... | 20th November, 2009
| Department of Rheumatology, Third Affiliated Hospital of Sun Yat-sen
| Scand J Rheumatol. 2009;38(6):455-459.
|
Agreement Between Quantiferon-TB Gold Test and Tuberculin Skin Test in the Identification of Latent Tuberculosis Infection in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.
OBJECTIVE: To compare the Quantiferon-TB Gold test (QTF-G) with the... | 18th November, 2009
| From the Division of Rheumatology and Department of Pulmonary and Critical
| J Rheumatol. 2009 Nov 16.
DOI Direct Link |
Etanercept therapy-associated acute uveitis: a case report and literature review.
A female patient diagnosed with ankylosing spondylitis experienced a new... | 18th November, 2009
| Department of Nephrology and Rheumatology, The Sixth People's Hospital
| Clin Exp Rheumatol. 2009 Sep-Oct;27(5):838-9.
|
Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population.
OBJECTIVE:Association between ankylosing spondylitis (AS) and two genes,... | 18th November, 2009
| Faculdade de Ciencias Medicas da Universidade Nova de Lisboa, Lisboa,
| Clin Exp Rheumatol. 2009 Sep-Oct;27(5):800-6.
|
Infliximab and anterior optic neuropathy: case report and review of the literature.
BACKGROUND: Anti-tumor necrosis factor alpha (TNF alpha) agents have been... | 17th November, 2009
| Department of Neurology and Ophthalmology, University of Kentucky College
| Graefes Arch Clin Exp Ophthalmol. 2009 Nov 15.
DOI Direct Link |
→View more research publications. |
Press Releases About Ankylosing Spondylitis:
|
 |
| Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers |
19th October, 2009 |
AstraZeneca |
-- Patients taking VIMOVO who were not taking LDA (n=653) experienced a
6.4% incidence of GU compared to 22.2% among those taking EC naproxen
(p<0.001)
Additional analyses
|
| New Data From the PRESTA Trial Demonstrate the Benefit of Enbrel(R) in Patients With Psoriasis and Psoriatic Arthritis |
9th October, 2009 |
|
MAIDENHEAD, England, October 9 /PRNewswire/ -- Data signalling that Enbrel(R) (etanercept) can improve the quality of
life for people with psoriasis and psoriatic arthritis were presented at the
18th
|
| SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector |
6th October, 2009 |
Schering-Plough Corporation |
-- For the treatment of severe, active AS in adult patients who have
responded inadequately to conventional therapy.
Centocor Ortho Biotech Inc. developed and discovered SIMPONI and
|
| SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis |
26th June, 2009 |
Schering-Plough Corporation |
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector
HORSHAM, Pa. and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ --
|
| Wyeth Presents New Analyses of Data From Three Studies of ENBREL(R) at the European League Against Rheumatism (EULAR) Annual Meeting |
12th June, 2009 |
|
MAIDENHEAD, England, June 12 /PRNewswire/ -- Analyses of data from three studies provide insight
into the use of ENBREL(R) (etanercept) in the treatment of three conditions
for which ENBREL is
|
Companies working in the area of Ankylosing Spondylitis from Bioportfolio's Biocorporate database : | |
| Company Name | |
EnbrelŪ (etanercept) is a TNF inhibitor approved for the following indications: moderately to severely active rheumatoid arthritis, polyarticular-course juvenile rheumatoid arthritis, psoriatic...
www.enbrel.com View full profile
| |
Boling Clinical Trials, Inc. is a freestanding clinical trials organization specializing in the therapeutic area of rheumatology and osteoporosis. From its humble beginnings with an occasional...
www.bolingclinical.com/ View full profile
| |
ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as...
www.enbrel.com/ View full profile
| | →View more Ankylosing Spondylitis related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for Ankylosing Spondylitis scientists - we have details of around 1055 individuals working on Ankylosing Spondylitis .
This page has been viewed 708 times
Recent Search Terms used to find this page: Ankylosing Spondylitis therapeutic area | ankylosing spondylitis studies november 2009 | ankylosing spondylitis, ppt | ankylosing spondylitis.ppt | ankylosing treatment 2009 Oct | ppt of ankylosing spondylitis treatment | ppt of ankylosing spondylitis treatment | ortho spondylitis | golimumab in ankylosing spondylitis.ppt | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Ankylosing Spondylitis across BioPortfolio, or for Ankylosing Spondylitis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
